Home/Glycadia Pharmaceuticals/Patrick M. O’Keefe
PM

Patrick M. O’Keefe

Chief Executive Officer

Glycadia Pharmaceuticals

Glycadia Pharmaceuticals Pipeline

DrugIndicationPhase
GLY-230Diabetic complications (Nephropathy focus)Phase 2
GLY-220Diabetic macrovascular diseasePre-clinical
ES12 mAbDiabetic macrovascular diseasePre-clinical
A717 mAbDiabetic microvascular diseasePre-clinical